J

JCR Pharmaceuticals Co Ltd
TSE:4552

Watchlist Manager
JCR Pharmaceuticals Co Ltd
TSE:4552
Watchlist
Price: 703 JPY 1.01% Market Closed
Market Cap: 91.2B JPY

Wall Street
Price Targets

Price Targets Summary
JCR Pharmaceuticals Co Ltd

Wall Street analysts forecast JCR Pharmaceuticals Co Ltd stock price to drop over the next 12 months.

According to Wall Street analysts, the average 1-year price target for JCR Pharmaceuticals Co Ltd is 689.23 JPY with a low forecast of 555.5 JPY and a high forecast of 829.5 JPY.

Lowest
Price Target
555.5 JPY
21% Downside
Average
Price Target
689.23 JPY
2% Downside
Highest
Price Target
829.5 JPY
18% Upside
JCR Pharmaceuticals Co Ltd Competitors:
Price Targets
000739
Apeloa Pharmaceutical Co Ltd
8% Upside
VIRP
Virbac SA
13% Upside
053030
Binex Co Ltd
94% Upside
000100
Yuhan Corp
29% Upside
NAVA
Navamedic ASA
69% Upside
XLY
Auxly Cannabis Group Inc
76% Upside

Revenue
Forecast

Revenue Estimate
JCR Pharmaceuticals Co Ltd

For the last 13 years the compound annual growth rate for JCR Pharmaceuticals Co Ltd's revenue is 8%. The projected CAGR for the next 3 years is 4%.

8%
Past Growth
4%
Estimated Growth
Estimates Accuracy
-3%
Average Miss

Operating Income
Forecast

Operating Income Estimate
JCR Pharmaceuticals Co Ltd

Operating Income forecast
is not available for
JCR Pharmaceuticals Co Ltd

Net Income
Forecast

Net Income Estimate
JCR Pharmaceuticals Co Ltd

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-6%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is JCR Pharmaceuticals Co Ltd's stock price target?
Price Target
689.23 JPY

According to Wall Street analysts, the average 1-year price target for JCR Pharmaceuticals Co Ltd is 689.23 JPY with a low forecast of 555.5 JPY and a high forecast of 829.5 JPY.

What is JCR Pharmaceuticals Co Ltd's Revenue forecast?
Projected CAGR
4%

For the last 13 years the compound annual growth rate for JCR Pharmaceuticals Co Ltd's revenue is 8%. The projected CAGR for the next 3 years is 4%.

Back to Top